NCT06790186Not yet recruiting
Improving Real-world Function for Persons with Schizophrenia: a Single-case Experimental Design
Improving Real-world Function for Persons with Schizophrenia (ImproFunc): a Single-case Experimental Design
Source: ClinicalTrials.gov · Last updated 23 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Existing treatment for individuals with psychosis primarily targets positive symptoms but has only modest effects on cognition and negative symptoms. Cognitive strategy training shows promising effects in reducing negative symptoms and increasing activity initiation in individuals with schizophrenia. This project aims to investigate the effect of the Perceive, Recall, Plan and Perform (PRPP) intervention in promoting effective use of cognitive strategies for adults with schizophrenia in performing their daily activities. Twenty-seven individuals with schizophrenia will be recruited from Sykehuset Innlandet (Innlandet Hospital Trust) and assessed using PRPP prior to an eight-session PRPP intervention. Re-assessment will be conducted after the intervention, as well as at 3 and 6 months, to evaluate the long-term effects of the intervention. A single-case design will be used to investigate the intervention's effects. The primary outcome measure will be the PRPP assessment, and the secondary outcome measure will be the Goal Attainment Scale (GAS). Generalization measures will be used to evaluate whether there are relevant changes beyond the primary and secondary goals.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 27 (estimated)
- First submitted
- 17 Jan 2025
- Start date
- 1 Feb 2025
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Sykehuset Innlandet HF
- Diseases
- Schizophrenia
- NCT number
- NCT06790186
What you commit to
- Study type: Interventional
- Planned participants: 27
- From 1 Feb 2025 to the primary completion date, 31 Dec 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Major physical disability, a current substance abuse problem, and cognitive deficits of organic origin or mental retardation
Who the study is looking for
- DSM-5 diagnosis of schizophrenia, understand and speak Norwegian, live in their own community context, but are patients in Sykehuset Innlandet ( Innlandet Hospital Trust), either as outpatients or on discharge from inpatient care, a subjective experience of functional impairment and/or cognitive difficulties identified in an initial interview, and a stable state without any major medication change for at least two months before inclusion
Age in the registry: 18 years to 59 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.